TY  - GEN
AU  - Monk,Bradley J
AU  - Herzog,Thomas J
AU  - Kaye,Stanley B
AU  - Krasner,Carolyn N
AU  - Vermorken,Jan B
AU  - Muggia,Franco M
AU  - Pujade-Lauraine,Eric
AU  - Park,Youn C
AU  - Parekh,Trilok V
AU  - Poveda,Andres M
TI  - Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis
SN  - 1879-0852
PY  - 2013///0307
KW  - Aged
KW  - Antibiotics, Antineoplastic
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Ovarian Epithelial
KW  - Dioxoles
KW  - Disease-Free Survival
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Neoplasms, Glandular and Epithelial
KW  - drug therapy
KW  - Ovarian Neoplasms
KW  - Polyethylene Glycols
KW  - Survival Analysis
KW  - Tetrahydroisoquinolines
KW  - Trabectedin
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.ejca.2012.04.001
ER  -